Heterologous expression of the C-terminal antigenic domain of the malaria vaccine candidate Pfs48/45 in the green algae Chlamydomonas reinhardtii.
about
Algae-based oral recombinant vaccinesThe Potential for Microalgae as Bioreactors to Produce PharmaceuticalsTransgene Expression in Microalgae-From Tools to ApplicationsPlastids: The Green Frontiers for Vaccine ProductionStrategies & recent development of transmission-blocking vaccines against Plasmodium falciparumConstruct design, production, and characterization of Plasmodium falciparum 48/45 R0.6C subunit protein produced in Lactococcus lactis as candidate vaccineExpression of Histophilus somni IbpA DR2 protective antigen in the diatom Thalassiosira pseudonana.Recent advances in recombinant protein-based malaria vaccines.Steps toward a globally available malaria vaccine: harnessing the potential of algae for future low cost vaccines.New tools for chloroplast genetic engineering allow the synthesis of human growth hormone in the green alga Chlamydomonas reinhardtii.Alga-produced cholera toxin-Pfs25 fusion proteins as oral vaccines.Single-dose microparticle delivery of a malaria transmission-blocking vaccine elicits a long-lasting functional antibody response.Photosynthetic biomanufacturing in green algae; production of recombinant proteins for industrial, nutritional, and medical uses.The potential of transgenic green microalgae; a robust photobioreactor to produce recombinant therapeutic proteins.Outlook in the application of Chlamydomonas reinhardtii chloroplast as a platform for recombinant protein production.Biotechnological exploitation of microalgae.Towards clinical development of a Pfs48/45-based transmission blocking malaria vaccine.The s48/45 six-cysteine proteins: mediators of interaction throughout the Plasmodium life cycle.Cisgenesis and intragenesis in microalgae: promising advancements towards sustainable metabolites production.Engineering biosynthesis of high-value compounds in photosynthetic organisms.Pilot-scale cultivation of wall-deficient transgenic Chlamydomonas reinhardtii strains expressing recombinant proteins in the chloroplast.Rice-produced MSP142 of Plasmodium falciparum elicits antibodies that inhibit parasite growth in vitro.Production of anti-cancer immunotoxins in algae: ribosome inactivating proteins as fusion partners.Expression, Purification and Characterization of GMZ2'.10C, a Complex Disulphide-Bonded Fusion Protein Vaccine Candidate against the Asexual and Sexual Life-Stages of the Malaria-Causing Plasmodium falciparum Parasite.In vivo production of non-glycosylated recombinant proteins in Nicotiana benthamiana plants by co-expression with Endo-β-N-acetylglucosaminidase H (Endo H) of Streptomyces plicatus.Production of recombinant proteins in microalgae at pilot greenhouse scale.Expanding the spectral palette of fluorescent proteins for the green microalga Chlamydomonas reinhardtii.Production of Recombinant Proteins in the Chloroplast of the Green Alga Chlamydomonas reinhardtii.
P2860
Q21131110-FFBCC487-6A12-497D-B3DB-CF5D1FA651FBQ26744351-7BB58899-3246-4D60-B1A5-F20642DAAE1EQ26752474-74978729-B843-4AED-B6A0-17EAE0B7EED1Q26774629-296BE7DA-0A72-47D7-B695-DB461BB9F3E9Q28072195-6FE235A3-B1C9-4D67-B1CE-662DB72FC299Q33750638-DEA18CEA-94A7-4FBD-91C8-E259C3F47678Q33841510-B75C8D3C-8FC6-499A-99B6-0CBD3B060621Q36394182-9F86CEAC-3BDB-449A-B7EE-289BD7E00FFEQ36892002-ABB701E5-9345-44F1-BE39-F01CA553F8A1Q36924094-9948D0BD-9DA7-4C07-A619-AE51B4ACBC37Q36970645-25A8107D-3258-4167-B55B-2FC9E875E5BEQ36998403-5C31345E-AC20-4D12-8330-7FD5303E2D01Q38198558-8E3B0AFA-A797-484A-B3AB-928C9BA6F116Q38239254-A0248D5D-BE1B-4C24-850C-9F4D237C808AQ38371816-B5D1B247-5C4B-494C-9212-10E77B0B53D6Q38591992-D8553A0E-FDE8-4C2A-8036-529C7C2A393BQ38775588-A95DFF5B-CE9C-4672-9694-844F0A7D15DDQ38789240-AE8D2627-8ED6-4417-B3F5-42FF70A984E3Q38797605-4974EFFE-8F17-4954-8641-6CD894930C29Q38814928-BD3D5147-465B-4FC0-99C5-4A990BB7F6EFQ38896345-BF91E86E-48C5-4709-92FD-29DB808F420FQ38942086-6B1D0BEA-95A1-4268-9D4D-19962B1AECF3Q39146031-A3EFD4C6-DD3E-4DC8-AC61-6209B6517478Q40159945-1E42B13D-78AC-417B-A881-50E19857F781Q41475379-CE4E6533-A8C5-40B9-A327-67BC3A83D48DQ42202179-79442141-58A3-4D12-97E3-AFD54AA02DB9Q46066746-66A396DD-AC60-47C9-8A32-1C459392D69AQ50238334-C0C50613-9407-4E80-B633-14BDEA4AA31F
P2860
Heterologous expression of the C-terminal antigenic domain of the malaria vaccine candidate Pfs48/45 in the green algae Chlamydomonas reinhardtii.
description
2012 nî lūn-bûn
@nan
2012年の論文
@ja
2012年学术文章
@wuu
2012年学术文章
@zh
2012年学术文章
@zh-cn
2012年学术文章
@zh-hans
2012年学术文章
@zh-my
2012年学术文章
@zh-sg
2012年學術文章
@yue
2012年學術文章
@zh-hant
name
Heterologous expression of the ...... gae Chlamydomonas reinhardtii.
@en
Heterologous expression of the ...... gae Chlamydomonas reinhardtii.
@nl
type
label
Heterologous expression of the ...... gae Chlamydomonas reinhardtii.
@en
Heterologous expression of the ...... gae Chlamydomonas reinhardtii.
@nl
prefLabel
Heterologous expression of the ...... gae Chlamydomonas reinhardtii.
@en
Heterologous expression of the ...... gae Chlamydomonas reinhardtii.
@nl
P2093
P2860
P1476
Heterologous expression of the ...... gae Chlamydomonas reinhardtii.
@en
P2093
Carla S Jones
James A Gregory
Michael Hannon
Miller Tran
Stephen P Mayfield
Steven P Briggs
Tiffany Luong
Zhouxin Shen
P2860
P2888
P304
P356
10.1007/S00253-012-4071-7
P407
P577
2012-05-18T00:00:00Z
P5875
P6179
1049092290